LAZERTINIB vs LEFLUNOMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAZERTINIB vs LEFLUNOMIDE: Safety Overview
| Metric | LAZERTINIB | LEFLUNOMIDE |
|---|---|---|
| Total FAERS Reports | 352 | 56,539 |
| Deaths Reported | 15 | 5,283 |
| Death Rate | 4.3% | 9.3% |
| Hospitalizations | 83 | 13,923 |
| Average Patient Age | 66.6 yrs | 51.3 yrs |
| % Female Patients | 59.9% | 87.3% |
| FDA Approval Date | Aug 19, 2024 | Apr 24, 2019 |
| Manufacturer | Janssen Biotech, Inc. | Alembic Pharmaceuticals Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |